Levesialle Continu

Ethinylestradiol, the active ingredient in Levesialle Continu, is a combined oral contraceptive presented as a tablet for oral use. Together with levonorgestrel, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation, altering cervical mucus, and thickening the endometrial lining to reduce implantation.

GNH USA supplies Levesialle Continu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this hormonal contraceptive for qualified prescribers and ensuring compliance with local regulatory standards.

Levesialle Continu, a combined oral contraceptive, is indicated for several gynecological and reproductive health purposes. Contraception: prevention of pregnancy in women of reproductive age. Menstrual cycle regulation: provides predictable bleeding patterns and reduces heavy menstrual bleeding. Acne management: decreases androgen‑driven skin lesions in women. Endometriosis symptom relief: reduces menstrual‑related pelvic pain. Cycle‑related dysmenorrhea: alleviates painful menstrual cramps.

Levesialle Continu may cause a range of adverse reactions. The frequency and severity vary among individuals.

Common Side Effects: - Nausea: mild stomach upset, often transient. - Headache: tension‑type or mild migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Breakthrough bleeding: spotting between scheduled periods.

Serious or Rare Side Effects: - Deep vein thrombosis: formation of blood clots in the legs. - Pulmonary embolism: clot migration to the lungs, a medical emergency. - Severe hypertension: sudden, significant increase in blood pressure.

Before prescribing Levesialle Continu, clinicians should evaluate individual risk factors and counsel patients on safe use. Medical evaluation: assess cardiovascular and thromboembolic risk prior to initiation. Smoking: avoid use in women over 35 who smoke. Drug interactions: review concomitant medications that affect hepatic enzymes. Pregnancy: discontinue immediately if pregnancy is confirmed. Breastfeeding: consult a physician before use. Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Levesialle Continu can interact with several drug classes, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive efficacy. - Antiretroviral protease inhibitors (e.g., ritonavir): can increase hormone levels and raise the risk of adverse events.

Moderate Interactions (Monitor Closely): - Rifampin and other strong antibiotics: may modestly lower contraceptive effectiveness. - St. John’s wort (herbal supplement): may decrease plasma hormone concentrations. - Thiazide diuretics: may increase the risk of hypertension while on the contraceptive.